Answers are grounded in this paper and cite their sources.
Introduction Combat-related traumatic brain injury (TBI) resulting from blast munitions (grenades, mortars, mines, bombs, artillery shells, etc.) has been a primary cause of military casualties over the past two decades, accounting for over 42% of post-evacuation combat deaths. Given the rising incidence of servicemen sustaining TBI combined with blast-induced neurotrauma (acoubarotrauma), optimizing pharmacological neuroprotection through positive modulators of heat shock protein 70 (HSP 70 ) represents an urgent medical priority. Aim To evaluate the neuroprotective efficacy of tamoxifen, melatonin, glutamine, Angiolin ([(S)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate]), and HSF-1 (heat shock factor 1) by assessing their effects on mitochondrial dysfunction and energy metabolism in an experimental model of TBI combined with blast injury. Materials and methods Combined TBI and blast injury was induced using a pressurized CO 2 stream via a gas-cylinder pneumatic device in 170 anesthetized male Wistar rats aged 3 months (weighing 230–240 g; n = 10 sham-operated). Melatonin (5 mg/kg), tamoxifen (1 mg/kg), glutamine (25 mg/kg), and piracetam (500 mg/kg) were administered intragastrically; HSF-1 (200 μL/kg) was injected intraperitoneally; and Angiolin gel (50 mg/kg) was delivered intranasally for 4 consecutive days immediately post-TBI. Animal mortality and neurological deficits were assessed. In blood serum, as well as cerebral cytosolic and mitochondrial fractions, levels of matrix metalloproteinase-9 (MMP-9), neuron-specific enolase (NSE), HSP70, ATP, ADP, AMP, malate, pyruvate, lactate, NAD+-malate dehydrogenase (NAD+-MDH) activity, mitochondrial permeability transition pore (mPTP) opening rate, and mitochondrial inner membrane potential (ΔΨm) were determined. Ultrastructural changes in the hippocampal CA1 subfield were examined via transmission electron microscopy. Results On day 4 post-TBI, untreated control animals exhibited severe neurological deficits, increased mortality, elevated circulating NSE ( p < 0.05) and MMP-9 ( p < 0.05), and a cytosolic/mitochondrial HSP 70 deficit ( p < 0.05). These changes were accompanied by secondary mitochondrial dysfunction: decreased ATP and ADP alongside increased AMP ( p < 0.05), elevated lactate with decreased pyruvate and malate ( p < 0.05), suppressed NAD+-MDH activity ( p < 0.05), loss of ΔΨm ( p < 0.05), accelerated mPTP opening ( p < 0.05), and an increased count of structurally compromised mitochondria ( p < 0.05). Treatment with the investigated agents upregulated HSP 70 expression, normalized energy metabolism, mitigated mitochondrial dysfunction, and provided overall neuroprotection. Comparative efficacy ranking demonstrated the following order: piracetam < glutamine < tamoxifen < melatonin < HSF-1 < Angiolin. Conclusion These findings substantiate the neuroprotective potential of HSP 70 modulators in experimental combined TBI and blast injury. Preclinical development of Angiolin gel and HSF-1 is experimentally justified as a promising neuroprotective strategy for blast-induced neurotrauma.
No takes yet. Share an insight, caveat, or question.
Belenichev et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: